Ajanta Pharma (AJANTPHARM) | Stock Overview & Key Data
Ajanta Pharma Performance Comparison
Stock Range
Today's Range
Low: ₹2,653.90
High: ₹2,716.00
on August 13, 2025
52 Week Range
Low: ₹2,327.30
High: ₹3,485.00
on April 7, 2025
on September 12, 2024
All-Time High: ₹3,485.00 on September 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR337.0B
EPS
74.45
P/E Ratio (TTM)
36.23
Forward P/E
27.17
P/B Ratio
8.94
PEG Ratio
27.17
Div. Yield
1.08%
ROE
24.28%
Beta
0.172
Debt to Equity
1.34
Financial Highlights
Profitability
Gross Margin
78.82%
Operating Margin
25.73%
Profit Margin
19.35%
Returns and Earnings
Return on Assets (TTM)
18.35%
Return on Equity (TTM)
24.28%
EBITDA
INR13.7B
Net Income (TTM)
INR9.3B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR384.74
Quarterly Revenue Growth (YoY)
13.80%
Quarterly Earnings Growth (YoY)
3.90%
Dividend Information
Last 12-Month Dividend
₹28.00
Current Dividend Yield
1.08%
3-Year Average Dividend Yield
0.90%
3-Year Average Annual Dividend
₹25.33
3-Year Total Dividends
₹76.00
Ex-Dividend Date
November 6, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma AJANTPHARM | 336.99B Large-cap | 2.33% | 1.92% | 8.66% | 7.25% | -9.92% | -9.95% | 107.94% | 66.27% |
| Sun Pharmaceutical SUNPHARMA | 3.81T Large-cap | -0.61% | -3.59% | -3.80% | -4.23% | -14.17% | -7.71% | 78.44% | 202.13% |
| Divi's Laboratories DIVISLAB | 1.59T Large-cap | -6.99% | -12.06% | 0.32% | -0.15% | -1.84% | 28.64% | 61.27% | 83.57% |
| Torrent TORNTPHARM | 1.21T Large-cap | 1.03% | 6.50% | 12.00% | 18.50% | 6.07% | 7.97% | 134.32% | 27.94% |
| Cipla CIPLA | 1.20T Large-cap | 1.45% | 2.53% | 0.66% | 5.00% | 2.85% | 5.70% | 47.71% | 100.01% |
| Dr. Reddy's DRREDDY | 1.02T Large-cap | 0.45% | -2.42% | 2.07% | 0.37% | -10.86% | -10.19% | 45.14% | 35.90% |
Ownership & Short Interest
Insider Ownership
59.74%
Institutional Ownership
21.76%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
78K
Average 90-Day Volume
146K
Ajanta Pharma Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Ajanta Pharma would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AJANTPHARM's 52-week high and low?
- In the last 52 weeks, Ajanta Pharma reached a high of ₹3,485.00 (on September 12, 2024) and a low of ₹2,327.30 (on April 7, 2025).
- What is the market cap and P/E ratio for AJANTPHARM?
- Curious about Ajanta Pharma's size and valuation? Its market capitalization stands at 336.99B. When it comes to valuation, the P/E ratio (trailing twelve months) is 36.23, and the forward P/E (looking ahead) is 27.17.
- Does AJANTPHARM pay dividends? If so, what's the yield?
- Yes, Ajanta Pharma is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.08%, and the company has paid an average of ₹25.33 per share annually over the past 3 years.
- Who are Ajanta Pharma's main competitors or similar companies to consider before investing?
When looking at Ajanta Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.81T Healthcare Drug Manufacturers - Specialty & Generic -7.71% 78.44% Divi's Laboratories
DIVISLAB1.59T Healthcare Drug Manufacturers - Specialty & Generic 28.64% 61.27% Torrent
TORNTPHARM1.21T Healthcare Drug Manufacturers - Specialty & Generic 7.97% 134.32% Cipla
CIPLA1.20T Healthcare Drug Manufacturers - Specialty & Generic 5.70% 47.71% Dr. Reddy's
DRREDDY1.02T Healthcare Drug Manufacturers - Specialty & Generic -10.19% 45.14% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ajanta Pharma Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Ajanta Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 24.28%, the Debt to Equity ratio from the most recent quarter is 1.34, and its Gross Profit Margin stands at 78.82%.
- What is the recent revenue and earnings growth for AJANTPHARM?
- Looking at Ajanta Pharma's growth, its revenue over the trailing twelve months (TTM) was INR48B. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.80%, and quarterly earnings saw a YoY growth of 3.90%.
- How much of AJANTPHARM stock is held by insiders and institutions?
- Wondering who owns Ajanta Pharma stock? Company insiders (like executives and directors) hold about 59.74% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 21.76%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.